Physician Assistant · Grosse Pointe Woods, MI
NPI
1285791293
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2021 Allard
Grosse Pointe Woods, MI, 48236
Phone (313) 417-3362
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
170 services
Medicare patients, 2024
123
Average age 68
Drug cost, 2024
$2.5M
843 prescriptions
Company payments, 2025
$99.98
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey McMahon was code 99213 (office e&m - established), 34 times for 32 patients. In total Jeffrey McMahon billed 170 services in 12 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 34 | 32 | $39.67 | $1,349 |
| 99214 Office E&M - Established | Facility | 25 | 24 | $59.44 | $1,486 |
| 91200 Standard X-ray | Facility | 18 | 18 | $7.02 | $126 |
| 99204 Office E&M - New | Facility | 15 | 15 | $90.75 | $1,361 |
By year: 2022 $11K for 176 services; 2023 $8,463 for 142 services; 2024 $10K for 170 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey McMahon prescribed most often to Medicare patients was Xifaxan (Rifaximin), with 93 prescriptions and refills. In total Jeffrey McMahon wrote 843 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xifaxan Rifaximin | 93 | 93 | 20 | $280K |
| Entecavir Generic | 84 | 142 | 20 | $13K |
| Ursodiol Generic | 75 | 117 | 19 | $8,267 |
| Epclusa Sofosbuvir/Velpatasvir | 72 | 73 | 30 | $1.7M |
| Azathioprine Generic | 68 | 150 | 20 | $3,967 |
| Spironolactone Generic | 66 | 146 | 20 | $888 |
| Furosemide Generic | 60 | 126 | 15 | $318 |
| Vemlidy Tenofovir Alafenamide | 53 | 59 | Under 11 | $72K |
| Prednisone Generic | 40 | 50 | Under 11 | $434 |
| Lactulose Generic | 29 | 37 | 12 | $938 |
| Midodrine Hcl Generic | 27 | 37 | Under 11 | $1,110 |
| Mavyret Glecaprevir/Pibrentasvir | 21 | 22 | 13 | $282K |
| Mycophenolate Mofetil Generic | 19 | 37 | Under 11 | $5,702 |
| Omeprazole Generic | 15 | 35 | Under 11 | $85.98 |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 11 | 11 | Under 11 | $82K |
Brand drugs: 279 claims; generic drugs: 564 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey McMahon $99.98 ($99.98 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $99.98.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $99.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.